Telmisartan reverses insulin resistance in mice

Telmisartan reverses insulin resistance in mice
Treating mice fed a high-fat diet with telmisartan reverses insulin resistance and glucose intolerance, but only when the peroxisome proliferator-activated receptor-δ gene is present, according to a study published online Dec. 13 in Diabetes.

(HealthDay)—Treating mice fed a high-fat diet with telmisartan reverses insulin resistance and glucose intolerance, but only when the peroxisome proliferator-activated receptor-δ (PPAR-δ) gene is present, according to a study published online Dec. 13 in Diabetes.

Li Li, from the Chongqing Institute of Hypertension in China, and colleagues examined the effects of telmisartan, an angiotensin receptor blocker, on insulin signaling and glucose uptake in wild-type mice and mice lacking the PPAR-δ gene in muscle.

The researchers found that, in cultured myotubes, treatment with telmisartan correlated with increased PPAR-δ expression and activated transcriptional activity of PPPAR-δ. In cultured myotubes with palmitate-induced , enhanced insulin-stimulated phosphorylation of Akt and Akt substrate of 160 kDa as well as translocation of Glu4 to the plasma membrane was seen with telmisartan treatment. Antagonizing PPAR-δ or phosphatidylinositol-3 kinase inhibited these effects. In cultured myotubes, insulin-stimulated glucose uptake which was reduced by palmitate could be restored by telmisartan. Similar results were observed in vivo in wild-type mice, but not PPAR-δ , with telmisartan reversing high-fat diet-induced insulin resistance and glucose intolerance.

"In summary, we demonstrate that telmisartan has a profound role in the improvement of in skeletal muscle, which is associated with activation of the PPAR-δ/phosphatidylinositol 3-kinase pathway," Li and colleagues conclude. "These findings implicate PPAR-δ as a potential therapeutic target in the treatment of hypertensive subjects with insulin resistance."

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Fewer mitochondria in offspring of parents with diabetes

Mar 26, 2012

(HealthDay) -- Normal-weight, insulin-resistant individuals whose parents have type 2 diabetes have fewer mitochondria in their muscles due to lower expression of lipoprotein lipase (LPL), according to a study ...

Improving obesity-induced insulin sensitivity

Jun 01, 2012

In recent years, a growing body of evidence has linked inflammation to the development of insulin resistance. In insulin resistance, the hormone insulin is less effective in promoting glucose uptake from the bloodstream into ...

Apelin hormone injections powerfully lower blood sugar

Nov 04, 2008

By injecting a hormone produced by fat and other tissues into mice, researchers report in the November Cell Metabolism that they significantly lowered blood sugar levels in normal and obese mice. The findings suggest that t ...

Scientists find 'dual switch' regulates fat formation

Apr 08, 2011

New research by scientists at The Scripps Research Institute and collaborating institutions has identified a key regulator of fat cell development that may provide a target for obesity and diabetes drugs.

Recommended for you

Higher HDL cholesterol may help protect against cancer

Sep 26, 2014

(HealthDay)—Higher levels of high-density lipoprotein cholesterol (HDL-C) are associated with a decreased risk of cancer among individuals with type 2 diabetes, according to a study published online Sept. ...

User comments